Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference
Kenvue Inc. (NYSE: KVUE), the world's largest pure-play consumer health company by revenue, has announced its participation in the upcoming Consumer Analyst Group of New York (CAGNY) Conference. The presentation will take place on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time.
Key executives participating include Thibaut Mongon (CEO), Paul Ruh (CFO), and Charmaine England (Chief Growth Officer). The presentation will be accessible via live webcast on investors.kenvue.com, with a replay available afterward.
Kenvue's portfolio includes renowned brands such as Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena®, and Tylenol®. These science-backed products are globally recommended by healthcare professionals and build on more than a century of heritage in everyday care.
Kenvue Inc. (NYSE: KVUE), la più grande azienda al mondo nel settore della salute dei consumatori per fatturato, ha annunciato la sua partecipazione alla prossima Consumer Analyst Group of New York (CAGNY) Conference. La presentazione si terrà mercoledì 19 febbraio 2025, alle 15:00 ora orientale.
I principali dirigenti che parteciperanno includono Thibaut Mongon (CEO), Paul Ruh (CFO) e Charmaine England (Chief Growth Officer). La presentazione sarà accessibile tramite webcast dal vivo su investors.kenvue.com, con una registrazione disponibile successivamente.
Il portafoglio di Kenvue include marchi rinomati come Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® e Tylenol®. Questi prodotti supportati dalla scienza sono raccomandati a livello globale dai professionisti della salute e si basano su oltre un secolo di esperienza nella cura quotidiana.
Kenvue Inc. (NYSE: KVUE), la empresa de salud del consumidor más grande del mundo por ingresos, ha anunciado su participación en la próxima Consumer Analyst Group of New York (CAGNY) Conference. La presentación tendrá lugar el miércoles 19 de febrero de 2025, a las 3:00 p.m. hora del Este.
Los ejecutivos clave que participarán incluyen a Thibaut Mongon (CEO), Paul Ruh (CFO) y Charmaine England (Chief Growth Officer). La presentación será accesible a través de una transmisión en vivo en investors.kenvue.com, con una repetición disponible posteriormente.
El portafolio de Kenvue incluye marcas reconocidas como Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® y Tylenol®. Estos productos respaldados por la ciencia son recomendados a nivel mundial por profesionales de la salud y se basan en más de un siglo de experiencia en el cuidado diario.
Kenvue Inc. (NYSE: KVUE), 매출 기준으로 세계 최대의 소비자 건강 회사가 Consumer Analyst Group of New York (CAGNY) Conference에 참여한다고 발표했습니다. 발표는 2025년 2월 19일 수요일, 동부 표준시 오후 3:00에 진행됩니다.
참여하는 주요 경영진으로는 Thibaut Mongon (CEO), Paul Ruh (CFO), Charmaine England (Chief Growth Officer) 등이 있습니다. 발표는 investors.kenvue.com에서 실시간 웹캐스트를 통해 시청할 수 있으며, 이후 다시 볼 수 있는 녹화도 제공됩니다.
Kenvue의 포트폴리오에는 Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® 및 Tylenol®와 같은 유명 브랜드가 포함되어 있습니다. 이러한 과학 기반 제품은 전 세계 의료 전문가들에 의해 추천되며, 일상적인 케어에서 100년 이상의 유산을 바탕으로 하고 있습니다.
Kenvue Inc. (NYSE: KVUE), la plus grande entreprise de santé grand public au monde en termes de revenus, a annoncé sa participation à la prochaine Consumer Analyst Group of New York (CAGNY) Conference. La présentation aura lieu le mercredi 19 février 2025, à 15h00 heure de l'Est.
Les principaux dirigeants participants incluent Thibaut Mongon (PDG), Paul Ruh (directeur financier) et Charmaine England (directrice de la croissance). La présentation sera accessible en direct via webcast sur investors.kenvue.com, avec une rediffusion disponible par la suite.
Le portefeuille de Kenvue comprend des marques renommées telles que Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® et Tylenol®. Ces produits soutenus par la science sont recommandés à l'échelle mondiale par des professionnels de la santé et reposent sur plus d'un siècle d'héritage dans les soins quotidiens.
Kenvue Inc. (NYSE: KVUE), das weltweit größte Unternehmen im Bereich der Verbrauchergesundheit nach Umsatz, hat seine Teilnahme an der bevorstehenden Consumer Analyst Group of New York (CAGNY) Conference angekündigt. Die Präsentation findet am Mittwoch, den 19. Februar 2025, um 15:00 Uhr Eastern Time statt.
Zu den teilnehmenden Führungskräften gehören Thibaut Mongon (CEO), Paul Ruh (CFO) und Charmaine England (Chief Growth Officer). Die Präsentation wird über einen Live-Webcast auf investors.kenvue.com zugänglich sein, mit einer späteren Wiederholung.
Das Portfolio von Kenvue umfasst renommierte Marken wie Aveeno®, BAND-AID®, Johnson's®, Listerine®, Neutrogena® und Tylenol®. Diese wissenschaftlich fundierten Produkte werden weltweit von Gesundheitsfachleuten empfohlen und basieren auf mehr als einem Jahrhundert Erfahrung in der alltäglichen Pflege.
- None.
- None.
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213166395/en/
Investor Relations:
Sofya Tsinis
Kenvue_IR@Kenvue.com
Media Relations:
Melissa Witt
Media@Kenvue.com
Source: Kenvue
FAQ
When is Kenvue (KVUE) presenting at the CAGNY Conference 2025?
Which executives will represent Kenvue (KVUE) at the 2025 CAGNY Conference?
How can investors watch Kenvue's (KVUE) CAGNY Conference presentation?
What are the major consumer brands owned by Kenvue (KVUE)?
What is Kenvue's (KVUE) market position in the consumer health industry?
